This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Jul;4(7):838-9.

doi: 10.1016/j.cgh.2006.04.020.

Statins for hyperlipidemia in patients with chronic liver disease: are they safe?

Raj Vuppalanchi, Naga Chalasani

PMID: 16829348
DOI: 10.1016/j.cgh.2006.04.020

Editorial

Statins for hyperlipidemia in patients with chronic liver disease: are they safe?

Raj Vuppalanchi et al. Clin Gastroenterol Hepatol. 2006 Jul.

. 2006 Jul;4(7):838-9.

doi: 10.1016/j.cgh.2006.04.020.

Authors

Raj Vuppalanchi, Naga Chalasani

PMID: 16829348
DOI: 10.1016/j.cgh.2006.04.020

No abstract available

PubMed Disclaimer

Comment on

Incidence of statin hepatotoxicity in patients with hepatitis C.
Khorashadi S, Hasson NK, Cheung RC. Khorashadi S, et al. Clin Gastroenterol Hepatol. 2006 Jul;4(7):902-7; quiz 806. doi: 10.1016/j.cgh.2006.03.014. Epub 2006 May 11. Clin Gastroenterol Hepatol. 2006. PMID: 16697272
Severe hepatic side effects of ezetimibe.
Stolk MF, Becx MC, Kuypers KC, Seldenrijk CA. Stolk MF, et al. Clin Gastroenterol Hepatol. 2006 Jul;4(7):908-11. doi: 10.1016/j.cgh.2006.04.014. Epub 2006 Jun 22. Clin Gastroenterol Hepatol. 2006. PMID: 16797241

Similar articles

Use of statins in patients with liver disease.
Kalaitzakis E, Björnsson ES. Kalaitzakis E, et al. Minerva Gastroenterol Dietol. 2014 Mar;60(1):15-24. Minerva Gastroenterol Dietol. 2014. PMID: 24632765 Review.
Drug-induced liver injury associated with statins.
Russo MW, Scobey M, Bonkovsky HL. Russo MW, et al. Semin Liver Dis. 2009 Nov;29(4):412-22. doi: 10.1055/s-0029-1240010. Epub 2009 Oct 13. Semin Liver Dis. 2009. PMID: 19826975 Review.
Statins and hepatotoxicity: focus on patients with fatty liver.
Chalasani N. Chalasani N. Hepatology. 2005 Apr;41(4):690-5. doi: 10.1002/hep.20671. Hepatology. 2005. PMID: 15789367 Review. No abstract available.
The myth of statin-induced hepatotoxicity.
Bader T. Bader T. Am J Gastroenterol. 2010 May;105(5):978-80. doi: 10.1038/ajg.2010.102. Am J Gastroenterol. 2010. PMID: 20445507 Review. No abstract available.
[Adverse effects of lipid-lowering medications].
Fukumoto Y, Shimokawa H. Fukumoto Y, et al. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:165-72. Nihon Rinsho. 2007. PMID: 18074533 Review. Japanese. No abstract available.

See all similar articles

Cited by

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases.
Malhotra P, Gill RK, Saksena S, Alrefai WA. Malhotra P, et al. Front Med (Lausanne). 2020 Sep 2;7:467. doi: 10.3389/fmed.2020.00467. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32984364 Free PMC article. Review.
Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?
Enjoji M, Nakamuta M. Enjoji M, et al. World J Gastroenterol. 2010 Feb 21;16(7):800-3. doi: 10.3748/wjg.v16.i7.800. World J Gastroenterol. 2010. PMID: 20143458 Free PMC article. Review.
Statins in primary biliary cirrhosis: are they safe?
Abu Rajab M, Kaplan MM. Abu Rajab M, et al. Dig Dis Sci. 2010 Jul;55(7):2086-8. doi: 10.1007/s10620-009-0988-9. Epub 2009 Oct 1. Dig Dis Sci. 2010. PMID: 19795210
Lipid-lowering agents that cause drug-induced hepatotoxicity.
Bhardwaj SS, Chalasani N. Bhardwaj SS, et al. Clin Liver Dis. 2007 Aug;11(3):597-613, vii. doi: 10.1016/j.cld.2007.06.010. Clin Liver Dis. 2007. PMID: 17723922 Free PMC article. Review.
Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.
Calderon RM, Cubeddu LX, Goldberg RB, Schiff ER. Calderon RM, et al. Mayo Clin Proc. 2010 Apr;85(4):349-56. doi: 10.4065/mcp.2009.0365. Mayo Clin Proc. 2010. PMID: 20360293 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

K24 DK 069290/DK/NIDDK NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information